RxDoctor Payments Data

Robert Brown, PA

Physician Assistant · Middletown, CTNPI 1417378019

Payments from drug & device makers

$1,816in general payments, 2019–2025

Across 77 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$505
  • Takeda Pharmaceuticals U.S.A., Inc.$248
  • Ironwood Pharmaceuticals, Inc$194
  • Johnson & Johnson$192
  • Ardelyx, Inc.$149
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$145
  • plus $382 from 7 others

What the payments were for

  • Food & beverage$1,816100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,816 in reported general payments places this provider in the 85th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$20,797
Medicare patients
150
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide54$53,276
CreonLipase/Protease/Amylase26$27,372
MotegrityPrucalopride Succinate15$13,805
Mesalamine19$13,143
Dexlansoprazole DrDexlansoprazole47$11,631
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates117$6,970
Pantoprazole Sodium353$3,392
Rabeprazole Sodium36$3,226
SutabSod Sulf/Pot Chloride/Mag Sulf19$3,136
Omeprazole111$2,105
Lubiprostone21$1,563
Colestipol Hcl15$1,393
Colesevelam Hcl15$1,183
Esomeprazole Magnesium40$1,032
Famotidine63$990

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$505$80,64780 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$248$13,80515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in Middletown

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →